Dr. Afshin Dowlati, MD
Claim this profileUniversity Hospitals Cleveland Medical Center
Area of expertise
Lung Cancer
Afshin Dowlati, MD has run 11 trials for Lung Cancer. Some of their research focus areas include:
Small Cell Lung Cancer
Afshin Dowlati, MD has run 6 trials for Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Hospitals Cleveland Medical Center
Case Western Reserve University / University Hospitals Cleveland Medical Center
Clinical Trials Afshin Dowlati, MD is currently running
SW-682
for Solid Tumors
This is a first-in-human (FIH), Phase 1a/1b open-label, multicenter, dose escalation and dose expansion study of SW-682 in adult participants with metastatic or unresectable advanced solid tumors with or without Hippo pathway alterations that are refractory to, or have progressed, during or after appropriate prior systemic anticancer therapy, including chemotherapy, immunotherapy, radiation therapy or targeted therapy, or for which no treatment is available, or prior standard of care (SOC) therapy was not tolerated and for which there is no further SOC treatment available. The study includes a Part 1 (Phase 1a) dose escalation phase and a Part 2 (Phase 1b) dose expansion to optimize the dose to be used for further development. All participants will self-administer SW-682 by mouth in 28-day cycles.
Recruiting
1 award
Phase 1
6 criteria
SGN-PDL1V
for Cancer
This trial is testing a new drug, SGN-PDL1V, alone and with pembrolizumab, in patients with advanced solid tumors. The goal is to see if these treatments are safe and effective. SGN-PDL1V targets cancer cells directly, while pembrolizumab helps the immune system fight the cancer.
Recruiting
1 award
Phase 1
More about Afshin Dowlati, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 19 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Afshin Dowlati, MD has experience with
- Carboplatin
- Etoposide
- Nivolumab
- Atezolizumab
- BMS-986012
- RH324
Breakdown of trials Afshin Dowlati, MD has run
Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Afshin Dowlati, MD specialize in?
Afshin Dowlati, MD focuses on Lung Cancer and Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Afshin Dowlati, MD currently recruiting for clinical trials?
Yes, Afshin Dowlati, MD is currently recruiting for 6 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Afshin Dowlati, MD has studied deeply?
Yes, Afshin Dowlati, MD has studied treatments such as Carboplatin, Etoposide, Nivolumab.
What is the best way to schedule an appointment with Afshin Dowlati, MD?
Apply for one of the trials that Afshin Dowlati, MD is conducting.
What is the office address of Afshin Dowlati, MD?
The office of Afshin Dowlati, MD is located at: University Hospitals Cleveland Medical Center, Cleveland, Ohio 44106-5055 United States. This is the address for their practice at the University Hospitals Cleveland Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.